Nicola Gianotti

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 12

Top Venues

Drug design, development and therapy

Journal of medical virology

PloS one

HIV medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Francesca Alberton, Laura Galli, Riccardo Lolatto, Caterina Candela, Nicola Gianotti, Matteo Chiurlo, Martina Ranzenigo, Martina Strano, Alessia Uglietti, Antonella Castagna
Outcome of Darunavir-Cobicistat-Based Regimens in HIV-Infected People Who Have Experienced Virological Failure. Drug design, development and therapy 18 (2024)
Francesca Alberton, Laura Galli, Riccardo Lolatto, Caterina Candela, Nicola Gianotti, Matteo Chiurlo, Martina Ranzenigo, Martina Strano, Alessia Uglietti, Antonella Castagna
Outcome of Darunavir-Cobicistat-Based Regimens in HIV-Infected People Who Have Experienced Virological Failure. Drug design, development and therapy 18 (2024)
Diana Canetti, Laura Galli, Riccardo Lolatto, Silvia Nozza, Vincenzo Spagnuolo, Camilla Muccini, Benedetta Trentacapilli, Elena Bruzzesi, Martina Ranzenigo, Matteo Chiurlo, Antonella Castagna, Nicola Gianotti
Bictegravir/Emtricitabine/Tenofovir Alafenamide Treatment: Efficacy and Tolerability in Clinical Practice. Drug design, development and therapy 17 (2023)
Caterina Candela, Laura Galli, Alberto Rizzo, Davide Mileto, Diana Canetti, Nicola Gianotti, Angelo Roberto Raccagni, Costanza Bertoni, Maria Francesca Lucente, Maria Rita Gismondo, Antonella Castagna, Silvia Nozza
Mpox DNA clearance in semen over 6-month follow-up. Journal of medical virology 95 (12) (2023)
Francesca Alberton, Silvia Nozza, Angelo Roberto Raccagni, Laura Galli, Vincenzo Spagnuolo, Simona Bossolasco, Massimo Cernuschi, Diana Canetti, Hamid Hasson, Antonella Castagna, Nicola Gianotti
The Propensity for Long-Acting Cabotegravir and Rilpivirine Every Two Months Among HIV-Infected People Eligible for Treatment. Journal of medical virology (2022)
Martina Ranzenigo, Nicola Gianotti, Laura Galli, Andrea Poli, Andrea Mastrangelo, Elena Bruzzesi, Matteo Chiurlo, Silvia Nozza, Simona Bossolasco, Vincenzo Spagnuolo, Daniela Mancusi, Roberta Termini, Elisabetta Carini, Adriano Lazzarin, Antonella Castagna
Switching from a Non-Protease inhibitor-Based Regimen To the Fixed Dose Combination of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Clinical Practice. Drug design, development and therapy 16 (2022)
João Marques-Gomes, Matthew J Salt, Rita Pereira-Neto, Franca S Barteldes, Vera Gouveia-Barros, Alexandre Carvalho, Antonella d'Arminio Monforte, Alethse De-la-Torre-Rosas, Amy Harris, Catarina Esteves, Carcom Maor, Cristina Mora, Carla Oliveira, Cristina Sousa, Douglas D Richman, Esteban Martinez, Fábio Cota-Medeiros, Filipa Gramacho, Georg Martin Norbert Behrens, Graça Gonçalves, Helena Farinha, Isabel Nabais, Inês Vaz-Pinto, Juan Sierra-Madero, Joaquim Sousa-Gago, John Thornhill, José Vera, Maja Erceg-Tusek, Margarida Tavares, Miguel Vasconcelos, Nuno Fernandes, Nicola Gianotti, Nienke Langebeek, Paulo Anjos, Raquel Couto, Ricardo Fernandes, Reena Rajasuriar, Rosário Serrão, Shaun Watson, Teresa Branco, Tiago Teixeira, Vicente Soriano
Development of the HIV360 international core set of outcome measures for adults living with HIV: A consensus process. HIV medicine 23 (6) (2021)
Lavinia Fabeni, Maria Mercedes Santoro, Patrizia Lorenzini, Stefano Rusconi, Nicola Gianotti, Andrea Costantini, Loredana Sarmati, Andrea Antinori, Francesca Ceccherini-Silberstein, Antonella d'Arminio Monforte, Annalisa Saracino, Enrico Girardi, null On Behalf Of The Icona Foundation Study Cohort
Evaluation of HIV Transmission Clusters among Natives and Foreigners Living in Italy. Viruses 12 (8) (2020)
Nicola Gianotti, Camilla Muccini, Laura Galli, Andrea Poli, Vincenzo Spagnuolo, Andrea Andolina, Nadia Galizzi, Marco Ripa, Emanuela Messina, Pier Marco Piatti, Adriano Lazzarin, Antonella Castagna
Homeostatic model assessment for insulin resistance index trajectories in HIV-infected patients treated with different first-line antiretroviral regimens. Journal of medical virology 91 (11) (2019)
Nicola Gianotti, Andrea Poli, Silvia Nozza, Laura Galli, Nadia Galizzi, Marco Ripa, Marco Merli, Alessia Carbone, Vincenzo Spagnuolo, Adriano Lazzarin, Antonella Castagna
Durability of switch regimens based on rilpivirine or on integrase inhibitors, both in association with tenofovir and emtricitabine, in HIV-infected, virologically suppressed patients. BMC infectious diseases 17 (1) (2017)
Nicola Gianotti, Andrea Poli, Laura Galli, Michela Franzin, Patrizia Tadini, Nadia Galizzi, Alessia Carbone, Marco Merli, Camilla Muccini, Chiara Oltolini, Andrea Andolina, Vincenzo Spagnuolo, Adriano Lazzarin, Antonella Castagna
Efficacy and safety of switching from branded to generic antiretrovirals in virologically suppressed HIV-infected patients. PloS one 12 (8) (2017)
Nicola Gianotti, Alessandro Cozzi-Lepri, Andrea Antinori, Antonella Castagna, Andrea De Luca, Benedetto Maurizio Celesia, Massimo Galli, Cristina Mussini, Carmela Pinnetti, Vincenzo Spagnuolo, Antonella d'Arminio Monforte, Francesca Ceccherini-Silberstein, Massimo Andreoni, null null
Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patients. PloS one 12 (2) (2017)

Nicola Gianotti.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Nicola Gianotti